GV 971 Sodium Oligomannate
New era for people living with dementia and Alzheimer's disease
GV-971 is the world’s first substance to break new ground in the treatment of Alzheimer’s disease (AD), the most common cause of dementia. Developed after years of intensive research, GV-971 is now at the forefront of innovation, offering hope to millions of people around the world.
GV 971 Sodium Oligomannate
New era for people living with dementia and Alzheimer's disease
GV-971 is the world’s first substance to break new ground in the treatment of Alzheimer’s disease (AD), the most common cause of dementia. Developed after years of intensive research, GV-971 is now at the forefront of innovation, offering hope to millions of people around the world.
Pioneering solutions for treating Alzheimer's disease
The real game changer in the fight against dementia and Alzheimer's disease (AD)
Innovative mechanism
GV-971 works through a unique mechanism to modulate the gut microbiome, reducing inflammation co-responsible for disease
27 years of research
The results of clinical trials unequivocally show improved cognitive function in people with mild to moderate Alzheimer's.
Pioneering solutions for treating Alzheimer's disease
The real game changer in the fight against dementia and Alzheimer's disease (AD)
Innovative mechanism
GV-971 works through a unique mechanism to modulate the gut microbiome, reducing inflammation co-responsible for disease
27 years of research
The results of clinical trials unequivocally show improved cognitive function in people with mild to moderate Alzheimer's.
Medical challenge of our times
Effective response to the devastating consequences of Alzheimer's disease
Alzheimer's disease gradually takes away our most precious things - our memories, our independence, our ability to recognize the people we love. From minor forgetfulness to a profound inability to live independently.
Our latest research opens the door to understanding and treating neurodegenerative diseases. GV-971 works where other therapies fail - by focusing on AD's unique pathway. Take advantage of the treatment and provide your loved ones with hope for a secure future.
It is estimated that more than 50 million people worldwide suffer from Alzhaimer's disease. That number will triple by 2050 to include 152 million patients
Recent studies indicate that people infected with SARS-CoV-2 (COVID-19) virus have a risk of developing AD that is up to 80% higher
Medical challenge of our times
Effective response to the devastating consequences of Alzheimer's disease
Alzheimer's disease gradually takes away our most precious things - our memories, our independence, our ability to recognize the people we love. From minor forgetfulness to a profound inability to live independently. Our latest research opens the door to understanding and treating neurodegenerative diseases. GV-971 works where other therapies fail - by focusing on AD's unique pathway. Take advantage of the treatment and provide your loved ones with hope for a secure future.
It is estimated that more than 50 million people worldwide suffer from Alzhaimer's disease. That number will triple by 2050 to include 152 million patients
Recent studies indicate that people infected with SARS-CoV-2 (COVID-19) virus have a risk of developing AD that is up to 80% higher
Hope for people with Alzheimer's disease and improved cognitive function - available to everyone
GV-971 is a remedy not only for those affected by Alzheimer's disease. In an individualized dose, it leads to significant improvements in memory, concentration and cognitive performance of the mind. It provides an excellent solution for people who are concerned about unleashing their full cognitive potential. GV-971 offers a wide range of benefits for the health of our brain and the neurological processes taking place in it.
clinical study in Shanghai
completed phase III clinical trial
Hope for people with Alzheimer's disease and improved cognitive function - available to everyone
GV-971 is a remedy not only for those affected by Alzheimer's disease. In an individualized dose, it leads to significant improvements in memory, concentration and cognitive performance of the mind. It provides an excellent solution for people who are concerned about unleashing their full cognitive potential. GV-971 offers a wide range of benefits for the health of our brain and the neurological processes taking place in it.
clinical study in Shanghai
completed phase III clinical trial
